Clinical and Basic Study for Pediatric Liver Transplantation
CBSPLT
1 other identifier
observational
180
1 country
1
Brief Summary
Background: In mainland China, the development of pediatric liver transplantation (LT) has lagged behind that of adult LT during the past two decades, but it has been progressing immensely in recent years. Renji hospital(shanghai) is currently the largest pediatric transplant center in mainland China. Aim and method: This study is performed for establishment of key techniques for pediatric LT in mainland China, including the indications and timing for pediatric LT, the criteria for donor selections, living donor LT planning, prevention and treatment for posttransplant complications, long-term follow-up management et al.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2015
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
July 17, 2015
CompletedFirst Posted
Study publicly available on registry
July 21, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2018
CompletedJuly 21, 2015
July 1, 2015
3 years
July 17, 2015
July 17, 2015
Conditions
Outcome Measures
Primary Outcomes (3)
Patient survival
up to 36 months
Graft survival
up to 36 months
Annual caseload for pediatric liver transplantation
up to 36 months
Eligibility Criteria
Pediatric liver transplantation cases
You may qualify if:
- Children with end-stage liver diseases
- Children with metabolic disorders for whom liver transplantation are required
- Children with fulminant liver failure
- Children with unresectable hepatic tumors
- Other miscellaneous conditions which need liver transplantation
You may not qualify if:
- Recipient age ≥ 18 years
- Patients with metastatic liver tumors
- Severe systmatic infections
- Acquired Immune Deficiency Syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- RenJi Hospitallead
Study Sites (1)
Deparment of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, 200127, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Qiang Xia, MD, PhD
Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2015
First Posted
July 21, 2015
Study Start
July 1, 2015
Primary Completion
July 1, 2018
Study Completion
September 1, 2018
Last Updated
July 21, 2015
Record last verified: 2015-07